The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 100 participants.
Also called NCT05055804
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- XP Technology, LLC
- Registry
-
NCT05055804
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT05055804. Allocation not applicable; no masking; primary purpose supportive care. Start 2021-08-11 (actual); primary completion 2025-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
- Condition
- Diabetes Mellitus, Type 1
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- ELG
- Lead sponsor
- XP Technology, LLC
Record details
- Record id
cardio:ct-nct05055804- Content hash
e21e3626f0e95fcdae63b876f20112255206f587f5fb0f7c6858dc7325ebcf10